The value of CEA,CYFRA21-1 and CA125 tests in opportunistic screening for non-small cell lung cancer:a meta-analysis
Objective To evaluate the value of CEA,CYFRA21-1 and CA125 tests in opportunistic screening of non-small cell lung cancer(NSCLC)based on meta-analysis.Methods The original research literatures on the diagnostic value of CEA,CYFRA21-1 and CA125 in Chinese NSCLC patients were searched from databases of PubMed,Embase,The Cochrane Library,CNKI,VIP,Database and Wanfang database from establishment to June 2023.The literature screening,data extraction and quality evaluation were carried out independently by two researchers.The quality evaluation tool of diagnostic accuracy studies was used to evaluate the quality of the literature.A summary receiver operating characteristic(SROC)curve was used to assess the overall effectiveness of the tests.The outcome stability and publication bias were detected by using sensitivity analysis and Deeks'test.Results A total of 23 studies met the inclusion and exclusion criteria were included.The results of meta-analysis showed that the overall sensitivity of CEA,CYFRA21-1 and CA125 alone in the diagnosis of NSCLC was relatively low,it was 0.49(95％CI:0.43-0.55),0.56(95％CI:0.49-0.63)and 0.41(95％CI:0.33-0.49),respectively.The overall sensitivity of the combined detection of the three markers for the diagnosis of NSCLC increased to 0.83(95％CI:0.69-0.91),but the overall specificity decreased to 0.76(95％CI:0.69-0.83).Conclusions The single detection of CEA,CYFRA21-1 and CA125 is not recommended for screening NSCLC in population receiving physical examination.Although the sensitivity of the combined detection of CEA,CYFRA21-1 and CA125 for screening NSCLC is improved,but the specificity is decreased,the misdiagnosis rate is increased,so the screening effect is limited.
万方数据
维普
